Pharmaceutical Compounding and Sterile Preparations

0.0(0)
studied byStudied by 0 people
learnLearn
examPractice Test
spaced repetitionSpaced Repetition
heart puzzleMatch
flashcardsFlashcards
Card Sorting

1/81

flashcard set

Earn XP

Description and Tags

Vocabulary terms related to pharmaceutical compounding and sterile preparations.

Study Analytics
Name
Mastery
Learn
Test
Matching
Spaced

No study sessions yet.

82 Terms

1
New cards

Compounding

The process of combining, admixing, diluting, pooling, reconstituting, repackaging, or otherwise altering a drug product or bulk drug substance to create a sterile preparation.

2
New cards

Sterile Compounding

Combining or preparing medicines in such a way that they are free from living microorganisms.

3
New cards

CSPs

Compounded sterile preparations intended for human or animal use.

4
New cards

BUD

Beyond-use date; the date or time after which a CSP must not be used.

5
New cards

Aseptic Technique

A set of procedures designed to minimize contamination by pathogens.

6
New cards

ISO Class 5

An environment with a maximum allowable particles of 3,520 particles/m3 and is suitable for sterile compounding.

7
New cards

Endotoxins

Toxic substances bound to the bacterial cell wall that are released when the bacteria die.

8
New cards

Validation

The process of proving that a procedure, process, or activity will consistently lead to the expected results.

9
New cards

SOP

Standard Operating Procedure; a set procedure followed for routine operations.

10
New cards

Personal Protective Equipment (PPE)

Clothing or equipment worn by an employee for protection against hazards.

11
New cards

Immediate-Use CSPs

CSPs intended for administration within 4 hours of compounding.

12
New cards

Media-Fill Test

A test conducted to evaluate the ability of compounding personnel to prepare sterile products.

13
New cards

Garbing

The process of dressing in specific attire to minimize contamination risk.

14
New cards

Cleanroom

A controlled environment designed to keep out pollutants like dust, particles, and microorganisms.

15
New cards

HEPA Filter

High-efficiency particulate air filter that removes particles from the air.

16
New cards

Agycocod, a.s. or q.s.

A term used to denote that sufficient quantity of a certain ingredient is prepared or to reach a desired concentration.

17
New cards

Container Closure System

Packaging components that protect the integrity of a drug product.

18
New cards

Pharmaceutical Isolator

A barrier system utilized for the compounding of sterile preparations that creates a controlled environment.

19
New cards

Compounding Allergenic Extracts

The preparation of allergenic extracts for immunotherapy.

20
New cards

Repackaging

The act of transferring a sterile product from one container to another.

21
New cards

Quality Assurance (QA)

A system of procedures to ensure that compounding processes meet specified quality standards.

22
New cards

Quality Control (QC)

The process of testing and inspection to ensure that products meet quality standards.

23
New cards

Visual Inspection

A method to check CSPs for visible defects before release.

24
New cards

Active Pharmaceutical Ingredient (API)

The substance in a drug that produces its effects.

25
New cards

Trypticase Soy Agar (TSA)

A nutrient agar used for culturing bacteria.

26
New cards

Sporicidal Disinfectant

A disinfectant that kills bacterial and fungal spores.

27
New cards

Compounding Record (CR)

A document that captures the details of each compounding process.

28
New cards

Training and Competency Assessment

Evaluating personnel's ability to perform specific tasks related to compounding.

29
New cards

Microbial Monitoring Program

A system used to assess the levels of microorganisms in a sterile compounding environment.

30
New cards

Action Levels

Specified limits for acceptable counts of microorganisms in monitoring programs.

31
New cards

Environmental Monitoring

The process of assessing air and surface quality in sterile compounding areas.

32
New cards

Storage Conditions

The environmental conditions under which CSPs are kept to ensure their stability.

33
New cards

Container Closure Integrity

The ability of a container closure to maintain its sterile status.

34
New cards

Antimicrobial Effectiveness Testing

Testing to confirm that a preservative in a CSP effectively inhibits microbial growth.

35
New cards

CSP Quality

The assessment of compounded pharmaceutical preparations for potency, purity, and sterility.

36
New cards

Compounding Environment

The area where CSPs are prepared, often subject to strict cleanliness and sterility standards.

37
New cards

Personnel Hygiene

Practices followed by compounding personnel to maintain cleanliness and reduce contamination risk.

38
New cards

Compounding Aseptic Containment Isolator (CACI)

A type of isolator that provides protection to the operator when compounding hazardous drugs.

39
New cards

Cleaning and Disinfecting Procedures

Protocols for maintaining cleanliness and reducing microbial contamination in compounding spaces.

40
New cards

Prescription Set

A set of allergenic extracts prepared for individual patient administration.

41
New cards

Biohazard Waste

Waste containing potentially infectious materials.

42
New cards

Container Integrity Testing

Testing to ensure that container closure systems maintain sterility.

43
New cards

Temperature and Humidity Monitoring

Monitoring environmental conditions to ensure they remain within acceptable limits for compounding.

44
New cards

Patient Safety

Practices intended to minimize the risk of harm to patients during compounding operations.

45
New cards

Cross-Contamination

Contamination of a drug product with another substance.

46
New cards

Quality Management System

A system that oversees quality processes and ensures compliance with standards.

47
New cards

Sterility Assurance Level (SAL)

The probability that a process has achieved sterility, usually set at 10^-6.

48
New cards

Component Evaluation

Assessing the quality and suitability of supply components before use.

49
New cards

Multiple-Dose Container

A container designed for multiple uses of a single sterile product.

50
New cards

Adverse Event Reporting

Reporting events that may indicate quality issues or harm related to CSPs.

51
New cards

Primary Engineering Control (PEC)

A device that provides an ISO Class 5 air quality environment for sterile compounding.

52
New cards

Segregated Compounding Area (SCA)

An area designated for the compounding of Category 1 CSPs.

53
New cards

Category 1 CSP

Compounded sterile preparations with a BUD of 12 hours or less.

54
New cards

Category 3 CSP

Compounded sterile preparations with longer BUDs subject to stringent sterility testing.

55
New cards

Air Changes per Hour (ACPH)

The number of times the entire air volume in a defined space is replaced in one hour.

56
New cards

Quality Control Procedures

Systems used to check CSPs for quality before release.

57
New cards

Sterility Testing

Testing designed to determine whether a compounded preparation is free from viable microorganisms.

58
New cards

Recertification

The process of validating equipment or environments to ensure ongoing compliance with standards.

59
New cards

Compliance Monitoring

The oversight of practices to ensure they meet regulatory requirements.

60
New cards

Handling Instructions

Specific directives for the safe handling of CSPs during transport.

61
New cards

Cleaning Agent

Substance used to remove contaminants from surfaces.

62
New cards

Surgical Asepsis

Techniques to keep sterile field areas free from all microorganisms.

63
New cards

Contamination Control

Methods employed to prevent the introduction of pathogens or unwanted substances into CSPs.

64
New cards

Hazardous Drugs (HDs) Guidelines

Protocols for handling drugs that pose special risks.

65
New cards

Incompatibility

A characteristic of drugs that indicates they should not be mixed.

66
New cards

Quality Assessment

The ongoing evaluation of a process or product to ensure it meets quality standards.

67
New cards

Hazardous Drug Handling

Protocols for safely managing drugs that can be harmful to health.

68
New cards

Segregated-Area Compounding

Compounding performed in a designated area, intended for specific types of preparations.

69
New cards

Automated Compounding Device (ACD)

A device that automates the preparation of CSPs.

70
New cards

Controlled Temperature Environment

A storage area maintaining specific temperature ranges suitable for CSPs.

71
New cards

Fill Volume

The amount of solution contained within a vial or container.

72
New cards

Apyrogenicity

Absence of pyrogens, substances that cause fever in humans.

73
New cards

Action Plans for Quality Control Failures

Procedures implemented in response to quality assessment failures.

74
New cards

Storage Integrity Testing

Verifications conducted to ensure the integrity of storage containers.

75
New cards

Surgical Preps

Procedures for maintaining sterility before surgical operations.

76
New cards

Antineoplastic Drugs

Drugs used to treat cancer that require close safety and handling measures.

77
New cards

Final Quality Assurance Review

A comprehensive examination of CSP quality before release.

78
New cards

Labeling Errors Prevention

Practices aimed at avoiding mistakes in naming or describing CSPs.

79
New cards

Surface Sampling

The act of testing surfaces for microbial contamination within a cleanroom.

80
New cards

Quality Metrics

Data points, indicators, or measurements reflecting quality levels within a process.

81
New cards

Hazardous Waste Disposal

The proper disposal methods for pharmaceuticals that pose potential risks to health and the environment.

82
New cards

Final Yield Validation

Confirmation of expected output from compounding processes.